A.Vogel Echinaforce Strong** Tablets contain a high dose of echinacea purpurea (purple coneflower). This plant helps the natural defense system of the body's cells and supports the immune system*.
This plant helps the natural defense system of the body's cells and supports your immune system*.What do you use A.Vogel Echinaforce Strong** Tablets for?To support your resistance1*. With Echinaforce Strong**, you can do this with just one tablet a day. For good resistance, a healthy lifestyle is the first priority. The guidelines are simple: eat a healthy and varied diet (sufficient fresh fruit and vegetables daily), get enough rest and sleep, and exercise regularly, preferably in the fresh air. This keeps your resistance at a good level. In addition, you can support your body1* with Echinaforce from A.Vogel. The benefits of A.Vogel Echinaforce Strong** Tablets:• Supports your immune system1*• Helps your defense1*• 1 tablet per dayHow do you use A.Vogel Echinaforce Strong** Tablets?You can take one tablet once a day with some water. If desired, you can increase the dosage to 1 tablet 3 times a day. Echinaforce Strong** is highly concentrated. A daily dose of 1 tablet contains the ingredients of 1200 mg of plant extract (Echinacea purpurea herba and radix).A.Vogel helpsNature has a lot to offer to help you stay healthy. In the ecological A.Vogel gardens, the plants and herbs that form the basis for your A.Vogel products are therefore cared for with love. 1Echinacea purpurea. *Health claims awaiting European approval. **Echinaforce Strong is based on 1200 mg Echinacea extract compared to 490 mg in the basic formula. Food supplement - herbal preparation. Read the instructions for use before use.
EAN code:8711596579062
Functional NameEchinaforce Tablets
Specification of contents1 tablet = 750 mg
VariantStrong
Full DescriptionA.Vogel Echinaforce Strong 60 Tablets Box
Contents (Net)60 pieces
Claim descriptionResistance¹*Helps the body's defenses and thus has a positive influence on the immune system.¹*¹Echina palustrine*Health claim awaiting European approval.
Comment